rdf:type |
|
lifeskim:mentions |
umls-concept:C0006938,
umls-concept:C0018787,
umls-concept:C0023983,
umls-concept:C0030705,
umls-concept:C0205210,
umls-concept:C0205251,
umls-concept:C0231180,
umls-concept:C0279336,
umls-concept:C0444956,
umls-concept:C1274040,
umls-concept:C1510451,
umls-concept:C2603343
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-3-30
|
pubmed:abstractText |
Although angiotensin-converting enzyme inhibitors are recommended as first line therapy in patients with chronic heart failure, the target doses proven to be effective in major morbidity and mortality trials (e.g. captopril 50 mg b.i.d), are generally not used in daily practice in Belgium.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0001-5385
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-7
|
pubmed:dateRevised |
2009-6-11
|
pubmed:meshHeading |
pubmed-meshheading:10707752-Adolescent,
pubmed-meshheading:10707752-Adult,
pubmed-meshheading:10707752-Aged,
pubmed-meshheading:10707752-Aged, 80 and over,
pubmed-meshheading:10707752-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10707752-Belgium,
pubmed-meshheading:10707752-Captopril,
pubmed-meshheading:10707752-Dose-Response Relationship, Drug,
pubmed-meshheading:10707752-Female,
pubmed-meshheading:10707752-Heart Failure,
pubmed-meshheading:10707752-Humans,
pubmed-meshheading:10707752-Male,
pubmed-meshheading:10707752-Middle Aged,
pubmed-meshheading:10707752-Prospective Studies,
pubmed-meshheading:10707752-Time Factors,
pubmed-meshheading:10707752-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS).
|
pubmed:affiliation |
Department of Cardiology, University Hospital, Gent, Belgium.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|